ArticleBioscience reports2025
Restriction endonuclease selective inhibition by β-cyclodextrin sulfate.
Article in Bioscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Restriction endonucleases (REs) are sequence-specific DNA-cleaving enzymes that are widely used as tools in molecular biology. Although REs is not typically considered therapeutic targets, their inhibition provides a useful framework for understanding how DNA-binding enzymes can be differentially modulated. In this present study, we investigated the inhibitory activity of β-cyclodextrin sulfate (β-CDsul), a highly anionic macrocycle previously reported to act as a non-selective inhibitor of restriction enzymes. Using NdeI-linearised pBR322 as a defined substrate, we quantified the inhibition of EcoRI, HindIII, and VspI under optimised digestion conditions. β-CDsul inhibited EcoRI with substantially greater potency than HindIII or VspI, exhibiting a 13- to 27-fold difference in IC50 values. In contrast, EDTA inhibited all three enzymes with comparable potency, consistent with non-selective divalent metal ion chelation. Selective inhibition of EcoRI by β-CDsul was maintained in a dual-enzyme system containing both EcoRI and VspI, supporting an enzyme-dependent mode of action. These findings demonstrate that β-cyclodextrin sulfate acts as a selective inhibitor of EcoRI and highlight the potential of polyanionic macrocycles as biochemical probes for differential endonuclease activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.